Profile
| Metric | Value |
|---|---|
| Full Name | Insmed Incorporated |
| Ticker | NASDAQ: INSM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | |
| Website | insmed.com |
| Employees | 1,271 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $177.12 | |
| Price, 1D Change | +1.77% | |
| Market Cap | $38B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.59 | |
| Revenue | $364M | |
| Revenue, 1Y Change | +19.17% | |
| EPS | -$5.57 | |
| EPS, 1Y Change | -4.36% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | INSMD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$5.57 | |
| EPS Estimate | -$6.11 | |
| EPS Est. Change | -9.72% | |
| Revenue | $363.71M | |
| Revenue Estimate | $517.92M | |
| Revenue Est. Change | +42.40% | |
| Current Price | $177.12 | |
| Price Target | - | $220.00 |
| Price Tgt. Change | - | +24.21% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.21 | -$5.34 | -2.45% | |
| -$5.34 | -$5.57 | -4.32% | |
| -$6.11 | N/A | -9.72% | |
| -$3.51 | N/A | +36.90% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $303.53M | $305.21M | +0.55% | |
| $360.57M | $363.71M | +0.87% | |
| $517.92M | N/A | +42.40% | |
| $1.22B | N/A | +235.72% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +153.54% | |
| Price, 3Y | +797.26% | |
| Market Cap, 1Y | +201.44% | |
| Market Cap, 3Y | +1,310.67% | |
| Revenue, 1Y | +19.17% | |
| Revenue, 3Y | +92.99% | |
| EPS, 1Y | -4.36% | |
| EPS, 3Y | -43.68% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $177.12 | |
| SMA 200 | $125.70 | |
| SMA 200 vs Price | -29.03% | |
| SMA 50 | $188.77 | |
| SMA 50 vs Price | +6.58% | |
| Beta | 0.59 | |
| ATR | $6.69 | |
| 14-Day RSI | 41.49 | |
| 10-Day Volatility | 88.57% | |
| 1-Year Volatility | 51.36% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $363.71M | |
| EPS | -$5.57 | |
| Gross Profit | $272.91M | |
| Gross Margin | 75.04% | |
| Operating Profit | -$786.57M | |
| Operating Margin | -216.26% | |
| Net Income | -$913.77M | |
| Net Margin | -251.24% | |
| EBITDA | -$818.79M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 3.87 | |
| Current Ratio | 5.45 | |
| Quick Ratio | 5.12 | |
| - | ||
| F-Score | 3 | |
| Altman Z-Score | 9.63 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 84.50 | |
| PB Ratio | 39.95 | |
| EV/EBITDA | -37.72 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $285.38M | |
| Cash & Equivalents | $555.03M | |
| Total Assets | $2.03B | |
| Current Assets | $1.62B | |
| Total Liabilities | $1.74B | |
| Current Liabilities | $297.53M | |
| Total Debt | $1.31B | |
| Short Term Debt | $16.50M | |
| Accounts Payable | $73.03M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.15B | |
| Operating Expenses | $1.06B | |
| Cost Of Goods Sold | $90.79M | |
| SG&A | $461.12M | |
| D&A | $11.01M | |
| Interest Expense | $0.00 | |
| Income Tax | $3.71M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$683.88M | |
| CFI | -$583.18M | |
| CFF | $1.34B | |
| Capex | $21.92M | |
| Free Cash Flow | -$705.81M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Goldman Sachs | → | |
| Wells Fargo | → | |
| Cantor Fitzgerald | → | |
| Goldman Sachs | → | |
| TD Cowen | → | |
| Mizuho | → |
Analyst sentiment
Institutional ownership
Screeners with INSM
Data Sources & References
- INSM Official Website www.insmed.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1104506/000110450625000053/0001104506-25-000053-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1104506/000110450625000009/0001104506-25-000009-index.htm
- List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
- INSM Profile on Yahoo Finance finance.yahoo.com/quote/INSM
- INSM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/insm
FAQ
What is the ticker symbol for Insmed Incorporated?
The ticker symbol for Insmed Incorporated is NASDAQ:INSM
Does Insmed Incorporated pay dividends?
No, Insmed Incorporated does not pay dividends
What sector is Insmed Incorporated in?
Insmed Incorporated is in the Healthcare sector
What industry is Insmed Incorporated in?
Insmed Incorporated is in the Biotechnology industry
What country is Insmed Incorporated based in?
Insmed Incorporated is headquartered in United States
When did Insmed Incorporated go public?
Insmed Incorporated initial public offering (IPO) was on June 1, 2000
Is Insmed Incorporated in the S&P 500?
No, Insmed Incorporated is not included in the S&P 500 index
Is Insmed Incorporated in the NASDAQ 100?
Yes, Insmed Incorporated is included in the NASDAQ 100 index
Is Insmed Incorporated in the Dow Jones?
No, Insmed Incorporated is not included in the Dow Jones index
When was Insmed Incorporated last earnings report?
Insmed Incorporated's most recent earnings report was on October 30, 2025
When does Insmed Incorporated report earnings?
The next expected earnings date for Insmed Incorporated is February 19, 2026